Funding for commercialisation of products and services that address the impacts of COVID-19

COVID-19 TechVouchers provide matched funding for businesses to commercialise products and services that address the impacts of COVID-19.

Overview

Matched funding is available for technology-rich startups, scaleups or small and medium enterprises (SMEs) to collaborate with Publicly Funded Research Organisations (PFROs) to accelerate the commercialisation of innovative R&D products and services that address the impacts of COVID-19.

Examples of activities that may be funded include:

• access to research facilities and equipment such as electron microscopes, medical imaging, and other PRFO delivery partner facilities
• product or process design, such as engineering or technical design expertise to determine prototype structure, function or materials
• validating or demonstrating technical capabilities of a product, process or technology, including clinical trials and in-market validation
• funding toxicology studies on materials that could be incorporated into a new product
• testing and certification for supply of products
• enhancing existing product capabilities or enabling entry to international markets
• production of laboratory prototypes.

What are the eligibility criteria?

To be eligible, a business must:

• have an Australian business number (ABN) registered in NSW
• be based in NSW
• have operated for at least  12 months
• have fewer than 200 employees
• have at least $150,000 in sales revenue or operating expenditure within the last 12 months or previous financial year
• be able to co-invest at least 50% of eligible project budget
• propose a technology-based product or service that addresses the impacts of COVID-19
• be engaged with eligible PFRO for R&D collaboration and have obtained a quote from the PFRO for the R&D project.

How do you apply?

Find out more about eligibility and how to apply at COVID-19 TechVouchers.